287 related articles for article (PubMed ID: 10953177)
1. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.
Du Y; Dodel RC; Eastwood BJ; Bales KR; Gao F; Lohmüller F; Müller U; Kurz A; Zimmer R; Evans RM; Hake A; Gasser T; Oertel WH; Griffin WS; Paul SM; Farlow MR
Neurology; 2000 Aug; 55(4):480-3. PubMed ID: 10953177
[TBL] [Abstract][Full Text] [Related]
2. Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease.
Combarros O; Sánchez-Guerra M; Infante J; Llorca J; Berciano J
J Neurol; 2002 Sep; 249(9):1242-5. PubMed ID: 12242547
[TBL] [Abstract][Full Text] [Related]
3. Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage.
McCarron MO; Stewart J; McCarron P; Love S; Vinters HV; Ironside JW; Mann DM; Graham DI; Nicoll JA
Stroke; 2003 Oct; 34(10):e193-5. PubMed ID: 12947160
[TBL] [Abstract][Full Text] [Related]
4. SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele.
Spell C; Kölsch H; Lütjohann D; Kerksiek A; Hentschel F; Damian M; von Bergmann K; Rao ML; Maier W; Heun R
Dement Geriatr Cogn Disord; 2004; 18(3-4):245-9. PubMed ID: 15286454
[TBL] [Abstract][Full Text] [Related]
5. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
[TBL] [Abstract][Full Text] [Related]
6. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
7. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
Agarwal R; Tripathi CB
Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
[TBL] [Abstract][Full Text] [Related]
8. Alpha2 macroglobulin and the risk of Alzheimer's disease.
Dodel RC; Du Y; Bales KR; Gao F; Eastwood B; Glazier B; Zimmer R; Cordell B; Hake A; Evans R; Gallagher-Thompson D; Thompson LW; Tinklenberg JR; Pfefferbaum A; Sullivan EV; Yesavage J; Alstiel L; Gasser T; Farlow MR; Murphy GM; Paul SM
Neurology; 2000 Jan; 54(2):438-42. PubMed ID: 10668709
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1A polymorphism is not associated with late onset Alzheimer's disease.
Fidani L; Goulas A; Mirtsou V; Petersen RC; Tangalos E; Crook R; Hardy J
Neurosci Lett; 2002 Apr; 323(1):81-3. PubMed ID: 11911995
[TBL] [Abstract][Full Text] [Related]
10. Association of interleukin-1 gene polymorphisms with Alzheimer's disease.
Nicoll JA; Mrak RE; Graham DI; Stewart J; Wilcock G; MacGowan S; Esiri MM; Murray LS; Dewar D; Love S; Moss T; Griffin WS
Ann Neurol; 2000 Mar; 47(3):365-8. PubMed ID: 10716257
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between the interleukin-1alpha gene C(-889)T polymorphism and Alzheimer's disease in a Chinese population.
Tsai SJ; Liu HC; Liu TY; Wang KY; Hong CJ
Neurosci Lett; 2003 Jun; 343(2):93-6. PubMed ID: 12759172
[TBL] [Abstract][Full Text] [Related]
12. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
13. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
[TBL] [Abstract][Full Text] [Related]
14. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E: risk factor for Alzheimer disease.
Tsai MS; Tangalos EG; Petersen RC; Smith GE; Schaid DJ; Kokmen E; Ivnik RJ; Thibodeau SN
Am J Hum Genet; 1994 Apr; 54(4):643-9. PubMed ID: 8128961
[TBL] [Abstract][Full Text] [Related]
16. Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE?
Fernandez LL; Scheibe RM
Arq Neuropsiquiatr; 2005 Mar; 63(1):1-6. PubMed ID: 15830056
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
[TBL] [Abstract][Full Text] [Related]
18. No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Neurosci Lett; 2004 Apr; 360(1-2):25-8. PubMed ID: 15082170
[TBL] [Abstract][Full Text] [Related]
19. An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease.
Depboylu C; Lohmüller F; Gocke P; Du Y; Zimmer R; Gasser T; Klockgether T; Dodel RC
Dement Geriatr Cogn Disord; 2004; 17(3):170-3. PubMed ID: 14739540
[TBL] [Abstract][Full Text] [Related]
20. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism.
Grimaldi LM; Casadei VM; Ferri C; Veglia F; Licastro F; Annoni G; Biunno I; De Bellis G; Sorbi S; Mariani C; Canal N; Griffin WS; Franceschi M
Ann Neurol; 2000 Mar; 47(3):361-5. PubMed ID: 10716256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
